SARS-CoV-2 大流行对结直肠癌筛查延迟的影响:对分期迁移和死亡率增加的作用
该研究基于意大利筛查人群构建程序模型,评估结肠镜检查延迟对结直肠癌分期与死亡的影响。延迟超过4-6个月会显著增加晚期结直肠癌病例,延迟超过12个月还会显著增加死亡。
要点
- 延迟0-3个月时74%的结直肠癌预计为I-II期。
- 延迟7-12个月和超过12个月时晚期结直肠癌从26%分别升至29%和33%。
- 延迟从0-3个月增至超过12个月时总死亡数增加12.0%。
核心结论
- 筛查延迟超过4-6个月会显著增加晚期结直肠癌病例,延迟超过12个月还会增加死亡。
- 数据强调需要重新组织针对结直肠癌等高影响疾病的防治工作,以应对SARS-CoV-2未来可能的流行波或其他大流行。
研究设计与样本
- 构建程序模型,考虑结肠镜检查时间的延迟,并估算因患者分期迁移对死亡的影响。
- 使用意大利筛查人群的数据计算预期结直肠癌病例数。
- 通过荟萃分析方法评估结肠镜检查延迟对结直肠癌分期的影响以及分期对死亡的影响。
主要发现
- 延迟0-3个月时,74%的结直肠癌预计为I-II期。
- 延迟4-6个月时,I-II期增加2%,同时III-IV期相应减少(P = .068)。
- 与基线(0-3个月)相比,中度延迟(7-12个月)和长延迟(超过12个月)导致晚期结直肠癌显著增加(从26%分别升至29%和33%;P = .008和P < .001)。
- 从0-3个月延迟增至超过12个月时,总死亡数显著增加12.0%(P = .005)。
- 与基线相比,超过12个月延迟时按分期的死亡分布有显著变化(P < .001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The SARS-CoV-2 pandemic had a sudden, dramatic impact on healthcare. In Italy, since the beginning of the pandemic, colorectal cancer (CRC) screening programs have been forcefully suspended. We aimed to evaluate whether screening procedure delays can affect the outcomes of CRC screening. METHODS: We built a procedural model considering delays in the time to colonoscopy and estimating the effect on mortality due to up-stage migration of patients. The number of expected CRC cases was computed by using the data of the Italian screened population. Estimates of the effects of delay to colonoscopy on CRC stage, and of stage on mortality were assessed by a meta-analytic approach. RESULTS: With a delay of 0-3 months, 74% of CRC is expected to be stage I-II, while with a delay of 4-6 months there would be a 2%-increase for stage I-II and a concomitant decrease for stage III-IV (P = .068). Compared to baseline (0-3 months), moderate (7-12 months) and long (> 12 months) delays would lead to a significant increase in advanced CRC (from 26% to 29% and 33%, respectively; P = .008 and P < .001, respectively). We estimated a significant increase in the total number of deaths (+12.0%) when moving from a 0-3-months to a >12-month delay (P = .005), and a significant change in mortality distribution by stage when comparing the baseline with the >12-months (P < .001). CONCLUSIONS: Screening delays beyond 4-6 months would significantly increase advanced CRC cases, and also mortality if lasting beyond 12 months. Our data highlight the need to reorganize efforts against high-impact diseases such as CRC, considering possible future waves of SARS-CoV-2 or other pandemics.
引用
- Ricciardiello L, Ferrari C, Cameletti M, et al. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality. Clin Gastroenterol Hepatol. 2020. PMID: 32898707. doi:10.1016/j.cgh.2020.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。